What amount sold does Medical Technology Ventures, LLC report in Form D filings?

The latest linked filings report $8.9M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Medical Technology Ventures, LLC's most recent SEC filing?

Medical Technology Ventures, LLC's most recent Form D filing was on 2010-02-18.

How many investors does Medical Technology Ventures, LLC have?

The most recent Form D filing lists 1 investor(s).

What type of securities does Medical Technology Ventures, LLC offer?

Medical Technology Ventures, LLC's SEC Form D filings indicate equity offerings.

Medical Technology Ventures, LLC

CIK: 0001484387·Biotechnology·HONOLULU, HI·Limited Liability Company·Founded 2010

Reported Sold

$8,880,300

Total Filings

Identified Offerings

Last Filed

Feb 18, 2010

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Feb 18, 2010Form D — New notice

Reported sold: $4,440,150 · Target: $4,440,150

Rule 506·1 investor

Feb 18, 2010Form D — New notice

Reported sold: $4,440,150 · Target: $4,440,150

Rule 506·1 investor

Fundraising Profile

Exemptions

Rule 506

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$8,880,300

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Nicholas Susner

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 18, 2010	New	$4,440,150	$4,440,150	1
Feb 18, 2010	New	$4,440,150	$4,440,150	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Swep Bio, Inc.

Biotechnology

Offering target: $4,999,976

Filed Oct 29, 2026